Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure.

Journal: Journal of hypertension

Volume: 38

Issue: 1

Year of Publication: 2020

Affiliated Institutions:  Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia The Conway Institute, University College Dublin, Dublin, Ireland University of Tennessee Health Science Center, Memphis, Tennessee, USA Hypertension in Africa Research Team, Medical Research Council Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK Department of Internal Medicine, Holbaek Hospital, Holbaek Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, University of Southern Denmark, Odense, Denmark Foundation-Medical Research Institutes, Geneva, Switzerland Medaval Ltd., Dublin, Ireland Hypertension League of Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil Vascular Biology and Hypertension Group, University of Alabama at Birmingham, Birmingham, Alabama, USA Department of Medicine, Physiology and Pharmacology and Community Health Sciences, O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia American Heart Association, Dallas, Texas, USA Sydney Medical School, University of Sydney and Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR and University Paris Descartes, Paris, France FOSCAL, Instituto Masira, Facultad de Ciencias de la Salud, UDES, Bucaramanga, Colombia Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Oxford, UK Cardiovascular & Hormonal Research Laboratory, Department of Cardiology & Kolling Institute, Royal North Shore Hospital and Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia Department of Non Communicable and Mental Health, Pan American Health Organization, Washington, District of Columbia Department of Medicine, University of Alberta, Edmonton, Alberta, Canada Studium Patavinum, University of Padova, Padua Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano, IRCCS, San Luca Hospital Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy Imperial Clinical Trials Unit, Imperial College London, London, UK American Medical Association, Improving Health Outcomes, Chicago, Illinois Department of Medicine (Cardiology), Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York The James J. Peters VA Medical Center, Bronx, New York, USA Cardiology Unit, Department of Medicine, University of Padova, Town Hospital of Cittadella, Padova Department of Medical, Surgical, and Experimental Sciences, University of Sassari, Sassari, Italy Hypertension League, Department of Cardiology, Federal University of Goiás, Goiânia, Brazil Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Steno Diabetes Center Copenhagen, Gentofte, Denmark Third Department of Medicine, Hypertension Center STRIDE-, National and Kapodistrian University of Athens, School of Medicine, Sotiria Hospital, Athens, Greece.

Abstract summary 

: The Lancet Commission on Hypertension identified that a key action to address the worldwide burden of high blood pressure (BP) was to improve the quality of BP measurements by using BP devices that have been validated for accuracy. Currently, there are over 3000 commercially available BP devices, but many do not have published data on accuracy testing according to established scientific standards. This problem is enabled through weak or absent regulations that allow clearance of devices for commercial use without formal validation. In addition, new BP technologies have emerged (e.g. cuffless sensors) for which there is no scientific consensus regarding BP measurement accuracy standards. Altogether, these issues contribute to the widespread availability of clinic and home BP devices with limited or uncertain accuracy, leading to inappropriate hypertension diagnosis, management and drug treatment on a global scale. The most significant problems relating to the accuracy of BP devices can be resolved by the regulatory requirement for mandatory independent validation of BP devices according to the universally-accepted International Organisation for Standardization Standard. This is a primary recommendation for which there is an urgent international need. Other key recommendations are development of validation standards specifically for new BP technologies and online lists of accurate devices that are accessible to consumers and health professionals. Recommendations are aligned with WHO policies on medical devices and universal healthcare. Adherence to recommendations would increase the global availability of accurate BP devices and result in better diagnosis and treatment of hypertension, thus decreasing the worldwide burden from high BP.

Authors & Co-authors:  Sharman James E JE O'Brien Eoin E Alpert Bruce B Schutte Aletta E AE Delles Christian C Hecht Olsen Michael M Asmar Roland R Atkins Neil N Barbosa Eduardo E Calhoun David D Campbell Norm R C NRC Chalmers John J Benjamin Ivor I Jennings Garry G Laurent Stéphane S Boutouyrie Pierre P Lopez-Jaramillo Patricio P McManus Richard J RJ Mihailidou Anastasia S AS Ordunez Pedro P Padwal Raj R Palatini Paolo P Parati Gianfranco G Poulter Neil N Rakotz Michael K MK Rosendorff Clive C Saladini Francesca F Scuteri Angelo A Sebba Barroso Weimar W Cho Myeong-Chan MC Sung Ki-Chul KC Townsend Raymond R RR Wang Ji-Guang JG Willum Hansen Tine T Wozniak Gregory G Stergiou George G

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Gakidou E, Afshin A, Abajobir AA, Abate KH, Abbafati C, Abbas KM, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390:1345–1422.
Authors :  37
Identifiers
Doi : 10.1097/HJH.0000000000002246
SSN : 1473-5598
Study Population
Male,Female
Mesh Terms
Blood Pressure Determination
Other Terms
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
Netherlands